Functional Comparison of T Cells Recognizing Cytomegalovirus pp65 and Intermediate‐Early Antigen Polypeptides in Hematopoietic Stem‐Cell Transplant and Solid Organ Transplant Recipients
1Laboratory of Vaccine Research, 2Division of Virology, and 3Department of Biostatistics, Division of Information Sciences, Beckman Research Institute of the City of Hope, and 4Department of Hematology and Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California; 5Departments of Laboratory Medicine and Medicine, University of Washington, Seattle
The functional status of cytotoxic T lymphocyte (CTL) populations recognizing cytomegalovirus intermediate‐early antigen (IE1) and pp65 polypeptides was investigated in peripheral blood mononuclear cells from hematopoietic stem‐cell transplant (HSCT) and solid organ transplant recipients. Combined flow‐based CD107a/b degranulation/mobilization and intracellular cytokine (ICC) assays using peptide libraries as antigens indicated that a significantly higher proportion of pp65‐specific CTLs were in a more mature functional state, compared with IE1‐specific CTLs. Degranulation/multiple cytokine ICC assays also indicated that a significantly higher proportion of pp65‐specific than IE1‐specific CTLs secreted both interferon‐γ and tumor necrosis factor–α and possessed greater cytotoxic potential. These results support our earlier findings of functional differences between CTLs recognizing individual epitopes within the IE1 and pp65 antigens in healthy donors and HSCT recipients and extend them to a broader array of human leukocyte antigen–restricted responses to those antigens. We also provide evidence of a relationship between cytotoxic function and the ability of cytomegalovirus‐specific CTLs to secrete multiple cytokines.
Received 16 May 2006; accepted 18 July 2006; electronically published 11 October 2006.
Cited by
Online publication date: 18-Jul-2009.
CrossRef
Online publication date: 1-Jul-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Jul-2008.
CrossRef
Online publication date: 1-Jan-2008.
Online publication date: 1-Sep-2007.
CrossRef
-
Potential conflicts of interest: none reported.
Financial support: National Institutes of Health (grants P01‐CA30206 to S.J.F., J.A.Z., and D.J.D.; R01‐CA77544 to D.J.D.; R01‐AI058148 to J.A.Z.; and M01‐RR00043‐38 in support of the General Clinical Research Center at City of Hope); Leukemia and Lymphoma Society (award 6122‐02 to S.F.L. and Comprehensive Cancer Center grant CA33572 to City of Hope); Edwin and Bea Wolfe Charitable Foundation (support to the Laboratory of Vaccine Research).





